Sean Hall

Company: IOVANCE Biotherapeutics, Inc.

Job title: Senior Director - Research

Seminars:

Next-Gen TIL: Counteracting the Solid Tumor Microenvironment 9:30 am

Targeting immune checkpoint targets using gene editing Developing tethered cytokine approaches to increase TIL persistence post-infusion Enhancing tumor-specific immunity through enrichment and selectionRead more

day: Conference Day One